Orphazyme A/S (ORPH) Stock
ORPH is no longer traded. Orphazyme A/S was delisted from the Nasdaq in April 2022.
Prices on this page are historical; the last trade was April 27, 2022 at $0.34.
Orphazyme A/S stock price history
ORPH final trading statistics
- Final close
- $0.34
- Final trading day
- Apr 27, 2022
- Market cap at delisting
- $37.27M
- Shares outstanding
- 35.31M
- Final 52-week range
- $0.30 – $77.77
- Avg. volume (final 3 mo.)
- 1,307,351
- All-time high (split-adj.)
- $21.00 · Jun 2021
- All-time low (split-adj.)
- $0.32 · Apr 2022
- Return since IPO
- -96.5%
- Beta
- 0.80
- Book value / share
- $4.77
- Price / book
- 0.07
Orphazyme A/S annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2020 | $0.00 | -$633.2M | — |
| FY2019 | — | -$337.5M | -$2.64 |
| FY2018 | $0.00 | -$229.6M | -$1.98 |
| FY2017 | $0.00 | -$126.2M | -$1.69 |
| FY2016 | $0.00 | -$57.9M | -$1.02 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Orphazyme A/S
Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company focuses on the amplification of heat-shock proteins to develop and commercialize therapeutics for diseases caused by protein misfolding and aggregation, and lysosomal dysfunction, including lysosomal storage and neuromuscular degenerative diseases. Its lead candidate is the Arimoclomol, which is in clinical development for four orphan diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, Inclusion Body Myositis, and Gaucher disease. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.
Orphazyme A/S stock FAQ
What happened to Orphazyme A/S stock?
Orphazyme A/S stock was delisted from the Nasdaq. Its final close was $0.34 on April 27, 2022.
Is ORPH stock still trading?
No. ORPH was delisted from the Nasdaq in April 2022 and no longer trades on a U.S. exchange.
What was the last price of ORPH stock?
ORPH closed at $0.34 on its final trading day, April 27, 2022, for a market value of about $37.27M.
What were Orphazyme A/S's revenue and earnings in its last full fiscal year?
Orphazyme A/S reported revenue of $0.00 and net income of -$633.2M in fiscal 2020, its last full year as a public company.
When did Orphazyme A/S go public?
Orphazyme A/S stock began trading on September 29, 2020.